[1] KIKUCHI K,SAIGUSA D,KANEMITSU Y,et al.Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease[J].Nat Commun,2019,10(1):1835.
[2] CHENG H T,XU X,LIM P S,et al.Worldwide epidemiology of diabetes-related end-stage renal disease,2000-2015[J].Diabetes Care,2021,44(1):89-97.
[3] CHEN Y Y,CHEN D Q,CHEN L,et al.Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease[J].J Transl Med,2019,17(1):5.
[4] GOODMAN A L,GORDON J I.Our unindicted coconspirators:human metabolism from a microbial perspective[J].Cell Metab,2010,12(2):111-116.
[5] DU X,LIU J,XUE Y,et al.Alteration of gut microbial profile in patients with diabetic nephropathy[J].Endocrine,2021,73(1):71-84.
[6] TAO S,LI L,LI L,et al.Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy,type 2 diabetes mellitus and healthy controls:an analysis of the gut microbiota composition[J].Acta Diabetol,2019,56(5):581-592.
[7] LECAMWASAM A,NELSON T M,RIVERA L,et al.Gut microbiome composition remains stable in individuals with diabetes-related early to late stage chronic kidney disease[J].Biomedicines,2020,9(1):19.
[8] HE X,SUN J,LIU C,et al.Compositional alterations of gut microbiota in patients with diabetic kidney disease and type 2 diabetes mellitus[J].Diabetes Metab Syndr Obes,2022,15:755-765.
[9] YU W,SHANG J,GUO R,et al.The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy[J].Ren Fail,2020,42(1):1100-1110.
[10] CAI K,MA Y,CAI F,et al.Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury[J].Endocrine,2022,76(2):294-303.
[11] HUANG W,GUO H L,DENG X,et al.Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide[J].Exp Clin Endocrinol Diabetes,2017,125(2):98-105.
[12] TOLHURST G,HEFFRON H,LAM Y S,et al.Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2[J].Diabetes,2012,61(2):364-371.
[13] NI Y,ZHENG L,NAN S,et al.Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota[J].Acta Biochim Biophys Sin,2022,54(10):1406-1420.
[14] HERMAN-EDELSTEIN M,WEINSTEIN T,LEVI M.Bile acid receptors and the kidney[J].Curr Opin Nephrol Hypertens,2018,27(1):56-62.
[15] WANG X X,WANG D,LUO Y,et al.FXR/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity[J].J Am Soc Nephrol,2018,29(1):118-137.
[16] WANG X X,EDELSTEIN M H,GAFTER U,et al.G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes[J].J Am Soc Nephrol,2016,27(5):1362-1378.
[17] DING L,YANG Q,ZHANG E,et al.Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice[J].Acta Pharm Sin B,2021,11(6):1541-1554.
[18] WANG P,WANG T,ZHENG X,et al.Gut microbiota,key to unlocking the door of diabetic kidney disease[J].Nephrology,2021,26(8):641-649.
[19] MOSTERD C M,KANBAY M,VAN DEN BORN B J H,et al.Intestinal microbiota and diabetic kidney diseases:the role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression[J].Best Pract Res Clin Endocrinol Metab,2021,35(3):101484.
[20] SNELSON M,DE PASQUALE C,EKINCI E I,et al.Gut microbiome,prebiotics,intestinal permeability and diabetes complications[J].Best Pract Res Clin Endocrinol Metab,2021,35(3):101507.
[21] FANG Q,ZHENG B,LIU N,et al.Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease[J].Front Physiol,2021,12:682482.
[22] LU C C,HU Z B,WANG R,et al.Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy[J].Acta Pharmacol Sin,2020,41(8):1111-1118.
[23] PETI-PETERDI J.High glucose and renin release:the role of succinate and GPR91[J].Kidney Int,2010,78(12):1214-1217.
[24] SUN C Y,CHANG S C,WU M S.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition[J].PLoS One,2012,7(3):e34026.
[25] LU C C,MA K L,RUAN X Z,et al.Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy[J].Int J Med Sci,2018,15(8):816-822.
[26] MAFI A,NAMAZI G,SOLEIMANI A,et al.Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy:a randomized,double-blind,placebo-controlled trial[J].Food Funct,2018,9(9):4763-4770.
[27] MIRAGHAJANI M,ZAGHIAN N,MIRLOHI M,et al.The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients:a randomized controlled clinical trial[J].J Ren Nutr,2017,27(5):317-324.
[28] EVENEPOEL P,POESEN R,MEIJERS B.The gut-kidney axis[J].Pediatr Nephrol,2017,32(11):2005-2014.
[29] BLACK A P,ANJOS J S,CARDOZO L,et al.Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients?[J].J Ren Nutr,2018,28(3):208-214.
[30] LI Y J,CHEN X,KWAN T K,et al.Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A[J].J Am Soc Nephrol,2020,31(6):1267-1281.
[31] WANG S Y,CAI G Y,CHEN X M.Energy restriction in renal protection[J].Br J Nutr,2018,120(10):1149-1158.
[32] FENG Y,WENG H,LING L,et al.Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice[J].Int J Biol Macromol,2019,132:1001-1011.
[33] YANG J,DONG H,WANG Y,et al.Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis[J].Int J Biol Macromol,2020,163:442-456.
[34] CHEN Q,REN D,WU J,et al.Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota[J].J Nat Med,2021,75(1):84-98.
[35] ZHAO T,ZHANG H,YIN X,et al.Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats[J].Biomed Pharmacother,2020,129:110325.
[36] HAN X,WANG Y,ZHANG P,et al.Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db/db mice[J].Pharm Biol,2021,59(1):1077-1087.
[37] HU Z B,LU J,CHEN P P,et al.Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis[J].Theranostics,2020,10(6):2803-2816.
[38] CAI T T,YE X L,LI R R,et al.Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice[J].Front Pharmacol,2020,11:1249.
[39] MA Y,YOU X,MAI G,et al.A human gut phage catalog correlates the gut phageome with type 2 diabetes[J].Microbiome,2018,6(1):24.
[40] RASMUSSEN T S,MENTZEL C M J,KOT W,et al.Faecalvirome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model[J].Gut,2020,69(12):2122-2130. |
